Log In
Print
BCIQ
Print
Print this Print this
 

PR5i (DTP-HepB-Polio-Hib Pediatric hexavalent vaccine) (V419)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCombination vaccine against diphtheria, tetanus and pertussis (DTP), hepatitis B, polio and Haemophilus influenzae type B
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentRegistration
Standard IndicationBacterial infection
Indication DetailsVaccinate against DTP, hepatitis B, polio and Haemophilus influenzae type B; Vaccinate in children against DTP, hepatitis B, polio and Haemophilus influenzae type B
Regulatory Designation

U.S. - Undisclosed Review (Vaccinate in children against DTP, hepatitis B, polio and Haemophilus influenzae type B)

Partner

Merck & Co. Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today